The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection. - Makras P; Yavropoulou MP; Polyzos SA; Papapoulos SE; Georgakopoulou D; Papatheodorou A; Anastasilakis AD (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2024)